Crism Therapeutics 

€2.24
31
-€0.00-0% Tuesday 20:00

Statistics

Day High
0.014
Day Low
0.014
52W High
2.24
52W Low
0.014
Volume
0
Avg. Volume
0
Mkt Cap
115.89M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jun 23
€0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

1JanExpected
Q4 0
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-2.2MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow A7L.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues. The company also offers formulation and consultancy services. The company was formerly known as Amur Minerals Corporation and changed its name to CRISM Therapeutics Corporation in May 2024. CRISM Therapeutics Corporation was founded in 2016 and is based in Road Town, the British Virgin Islands.
Show more...
CEO
Country
Virgin Islands (British)
ISIN
VGG042401262
WKN
000A0JJTJ

Listings

0 Comments

Share your thoughts

FAQ

What is Crism Therapeutics stock price today?
The current price of A7L.STU is €2.24 EUR — it has decreased by -0% in the past 24 hours. Watch Crism Therapeutics stock price performance more closely on the chart.
What is Crism Therapeutics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Crism Therapeutics stocks are traded under the ticker A7L.STU.
Is Crism Therapeutics stock price growing?
A7L.STU stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Crism Therapeutics has showed a +0% increase.
What is Crism Therapeutics market cap?
Today Crism Therapeutics has the market capitalization of 115.89M
What is Crism Therapeutics revenue for the last year?
Crism Therapeutics revenue for the last year amounts to 0 EUR.
What is Crism Therapeutics net income for the last year?
A7L.STU net income for the last year is -2.2M EUR.
Does Crism Therapeutics pay dividends?
Yes, A7L.STU dividends are paid en. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Crism Therapeutics located?
Crism Therapeutics operates in the Materials sector.
When did Crism Therapeutics complete a stock split?
Crism Therapeutics has not had any recent stock splits.
Where is Crism Therapeutics headquartered?
Crism Therapeutics is headquartered in Road Town, Virgin Islands (British).